Építés alatt – nem éles oldal
Belépés
Taking people in KanadaNo phase

Comprehensive Assessment of Neurodegeneration and Dementia

Key facts

Where
Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, Peterborough, Québec, Sherbrooke, Toronto, Vancouver, Victoria és Waterloo, KanadaSee the 19 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 90 years old?

Forrás: NCT03402919: ki vehet részt

Where in Kanada

  • University Of CalgaryCalgary, KanadaTaking people
  • University of Alberta HospitalEdmonton, KanadaTaking people
  • Veteran's Memorial BuildingHalifax, KanadaTaking people
  • Hamilton General HospitalHamilton, KanadaTaking people
  • Gait and Brain LabLondon, KanadaTaking people
  • St. Joseph's Health Care LondonLondon, KanadaTaking people
  • Clinique de cognition Institut universitaire de gériatrie de MontréalMontreal, KanadaTaking people
  • Jewish General Hospital/McGill Memory ClinicMontreal, KanadaTaking people
  • Research Institute of the McGill University Health CentreMontreal, KanadaNo longer taking part
  • Bruyère Research InstituteOttawa, KanadaNo longer taking part
  • Kawartha CentrePeterborough, KanadaNo longer taking part
  • Hôpital Enfant-JésusQuébec, KanadaTaking people
  • Centre de recherche sur le vieillissement CIUSSS de l'Estrie-CHUSSherbrooke, KanadaNo longer taking part
  • Baycrest Clinical UnitToronto, KanadaTaking people
  • Sunnybrook Health Sciences CentreToronto, KanadaNo longer taking part
  • University Health Network Memory ClinicToronto, KanadaNo longer taking part
  • Djavad Mowafaghian Centre for Brain HealthVancouver, KanadaTaking people
  • Island HealthVictoria, KanadaToborzás még nem indult
  • University of WaterlooWaterloo, KanadaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
McGill University
Trial code
NCT03402919
Record updated
2026. január 20.
Original description
This is a longitudinal observational study recruiting individuals between the ages of 50 and 90 with different types of dementia as well as a comparison group without cognitive deficits. Participants are/will be recruited at sites across Canada and will undergo assessments, neuroimaging, and biological sample collection.Read full original descriptionShow less

The Comprehensive Assessment of Neurodegeneration and Dementia Study

This is a longitudinal observational study recruiting individuals between the ages of 50 and 90 with different types of dementia as well as a comparison group without cognitive deficits. Participants are/will be recruited at sites across Canada and will undergo assessments, neuroimaging, and biological sample collection.

Inclusion: Has subjective or objective cognitive impairment; Written informed consent must be obtained and documented (from the patient or, where jurisdictions allow it, from a caregiver/family member); Sufficient proficiency in English or French to undertake self report and neuropsychological testing; Geographic accessibility to the study site; Must have a study partner who can participate as required in the protocol (provide corroborative information); Up to 12 years of education; Fits into one of the following groups: Cognitively Unimpaired, Subjective Cognitive Impairment, Mild Cognitive Impairment, Vascular Mild Cognitive Impairment, Parkinson's Disease, Parkinson's Disease with Mild Cognitive Impairment.

Exclusion: The presence of other significant known chronic brain disease such as: moderate to severe chronic static leukoencephalopathy (including previous traumatic injury), multiple sclerosis, a serious developmental handicap, malignant tumors, Parkinson's disease (other than for the Parkinson's cohort), and other rarer brain illnesses; Ongoing alcohol or drug abuse which in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures; Symptomatic stroke within the previous year; Unable to undergo MRI scan due to medical contraindications or inability to tolerate the procedure.

ClinicalTrials.gov NCT03402919